SC 13G: INSMED Inc
Ticker: INSM · Form: SC 13G · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by INSMED Inc.
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001897612-24-001156 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0001897612-24-001156 Filing Date 2024-02-14 Accepted 2024-02-14 10:04:36 Documents 1 Confirming Copy Document Format Files Seq Description Document Type Size 1 insm13gdec23.txt SC 13G 5118 Complete submission text file 0001897612-24-001156.txt 6723 Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900 INSMED Inc (Subject) CIK : 0001104506 (see all company filings) EIN. : 541972729 | State of Incorp.: VA | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-59149 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202 Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000 T. Rowe Price Investment Management, Inc. (Filed by) CIK : 0001897612 (see all company filings) EIN. : 854328500 | State of Incorp.: MD | Fiscal Year End: 1231 Type: SC 13G